M. M. Batyushin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
M. M. Batyushin has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
A. A. Vachugova
Volgograd State Medical University
1 shared publication- A. V. Mukhtarova
Rostov State Medical University
1 shared publication A. V. Poddubnyi
Cardiology and Cardiovascular Surgery Centre, Regional Clinical Hospital
1 shared publication- A.V. Mukhtarova Mukhtarova
Railway Polyclinic No. 1 of the Clinical Hospital of the Russian Railways Hospital
1 shared publication D. G. Pasechnik
1 shared publicationE. G. Asrumian
1 shared publication
Latest Publications
- Open Access
- 31 December 2022
- Published by Rostov State Medical University in South Russian Journal of Therapeutic Practice
- Vol. 3 (4) , 77-83
The relationship of the total expression of transforming growth factor β1, monocytic chemoattractive protein-1, vascular endothelial growth factor-A in renal tissue with clinical and morphological manifestations in glomerulonephritis
Objective: to study the effect of the total expression of vascular endothelial growth factor A (VEGF A), tissue growth factor β1 (TGF-β1) and monocytic chemoattractant factor 1 (MCP-1) on the course of glomerulonephritis.Material and methods: the study was a prospective (12-month) open comparative clinical and morphological study with the inclusion of 75 patients aged 18 to 75 years (males - 52, females - 23) with glomerulonephritis in the acute stage. All patients were initially examined, including assessment of clinical, laboratory and instrumental parameters, including puncture nephrobiopsy. In addition to the standard, sections of biopsies were stained with labeled antibodies to VEGF A, TGF-β1 and MCP-1 to assess their expression in kidney tissue. After 12 months, the development of remission of glomerulonephritis, parameters of the general analysis of urine, creatinine, urea, uric acid of blood, calculation of GFR were evaluated.Results: it was found that the severity of the total expression of MCP-1+VEGF-A+TGFß1 is observed to a greater extent in hematuric forms of glomerulonephritis, occurring without changes in the level of blood albumin. The same follows from the results demonstrating the relationship of the total expression of MCP-1+VEGF-A+TGFß1 with morphological manifestations more characteristic of nephritic forms of glomerulonephritis (IgA deposits, mesangial hypercellularity). The increased expression of the studied factors has shown its influence on the development of fibrosis and thickening of the walls of renal vessels, glomerular fibrosis and interstitium, reflecting the whole complex of reparative remodeling of renal tissue in the inflammatory process. The effect of the total expression of MCP-1+VEGF-A+TGFß1 on the further course of glomerulonephritis, accompanied by the progression of the disease in the form of a decrease in GFR after 12 months of observation of patients, was revealed.Conclusions: an increase in the total expression of MCP-1+VEGF-A+TGFß1 in hematuric forms of glomerulonephritis indicates the role of these factors in the development of the inflammatory process to a greater extent in these forms of the disease. It was found that an increase in the severity of the total expression of MCP-1+VEGF-A+TGFß1 is associated with manifestations of renal remodeling in glomerulonephritis. It has been shown that an increase in the severity of the total expression of MCP-1+VEGF-A+TGFß1 is accompanied by an increase in the likelihood of a rapid decrease in renal function in glomerulonephritis at 12-month follow-up.
- 31 December 2022
- Published by Rostov State Medical University in South Russian Journal of Therapeutic Practice
- Vol. 3 (4) , 77-83
Open AccessThe relationship of the total expression of transforming growth factor β1, monocytic chemoattractive protein-1, vascular endothelial growth factor-A in renal tissue with clinical and morphological manifestations in glomerulonephritis
Objective: to study the effect of the total expression of vascular endothelial growth factor A (VEGF A), tissue growth factor β1 (TGF-β1) and monocytic chemoattractant factor 1 (MCP-1) on the course of glomerulonephritis.Material and methods: the study was a prospective (12-month) open comparative clinical and morphological study with the inclusion of 75 patients aged 18 to 75 years (males - 52, females - 23) with glomerulonephritis in the acute stage. All patients were initially examined, including assessment of clinical, laboratory and instrumental parameters, including puncture nephrobiopsy. In addition to the standard, sections of biopsies were stained with labeled antibodies to VEGF A, TGF-β1 and MCP-1 to assess their expression in kidney tissue. After 12 months, the development of remission of glomerulonephritis, parameters of the general analysis of urine, creatinine, urea, uric acid of blood, calculation of GFR were evaluated.Results: it was found that the severity of the total expression of MCP-1+VEGF-A+TGFß1 is observed to a greater extent in hematuric forms of glomerulonephritis, occurring without changes in the level of blood albumin. The same follows from the results demonstrating the relationship of the total expression of MCP-1+VEGF-A+TGFß1 with morphological manifestations more characteristic of nephritic forms of glomerulonephritis (IgA deposits, mesangial hypercellularity). The increased expression of the studied factors has shown its influence on the development of fibrosis and thickening of the walls of renal vessels, glomerular fibrosis and interstitium, reflecting the whole complex of reparative remodeling of renal tissue in the inflammatory process. The effect of the total expression of MCP-1+VEGF-A+TGFß1 on the further course of glomerulonephritis, accompanied by the progression of the disease in the form of a decrease in GFR after 12 months of observation of patients, was revealed.Conclusions: an increase in the total expression of MCP-1+VEGF-A+TGFß1 in hematuric forms of glomerulonephritis indicates the role of these factors in the development of the inflammatory process to a greater extent in these forms of the disease. It was found that an increase in the severity of the total expression of MCP-1+VEGF-A+TGFß1 is associated with manifestations of renal remodeling in glomerulonephritis. It has been shown that an increase in the severity of the total expression of MCP-1+VEGF-A+TGFß1 is accompanied by an increase in the likelihood of a rapid decrease in renal function in glomerulonephritis at 12-month follow-up.
- 2 September 2021
- Published by Non-profit organization Nephrology in Nephrology (Saint-Petersburg)
- Vol. 25 (5) , 92-98
Role of MCP-1 in the development of tubulointerstitial fibrosis in patients with primary chronic glomerulonephritis
BACKGROUND.To date, the study of the factors involved in the glomerular-tubular pathological connections leading to damage to the tubulointerstitial tissue is one of the topical areas of nephrology. THE AIM: to study the effect of MCP-1 in the development of tubulointerstitial fibrosis as a factor in the irreversible progression of chronic renal failure. PATIENTS ANDMETHODS.Prospective observation and retrospective analysis of case histories were carried out, which included a total of 75 patients with primary chronic glomerulonephritis. RESULTS.The average age of the patients was 36.7 ± 12.3 years, of which 52 were males, 23 were women. The average length of service in a nephrological disease was 3.0 [1.0; 5.0] years. The calculated GFR values are 87.3 ± 31.2 ml / min / 1.73 m2. In the general population, the moderate degree of MCP-1 expression, estimated at 2 points, was 35 %, pronounced expression was found in 25 % of the respondents. In the mesangium of the glomeruli and in macrophages, the expressed degree of MCP-1 expression was 20 % and 16 %, respectively, which characterizes MCP-1 as a marker produced by resident cells. When studying the relationship of MCP-1 in blood with clinical parameters, a correlation was found with the values of total protein (Rs= –0.43; p CONCLUSION.The relationship of serum and tissue forms of MCP-1 with the progression of tubulointerstitial fibrosis in chronic glomerulonephritis has been demonstrated. MCP-1-induced mesangial cell plays a critical role in the development of renal tubular damage, and its increased expression is associated with progressive tubulointerstitial fibrosis and decreased renal function.
- 2 September 2021
- Published by Non-profit organization Nephrology in Nephrology (Saint-Petersburg)
- Vol. 25 (5) , 92-98
Role of MCP-1 in the development of tubulointerstitial fibrosis in patients with primary chronic glomerulonephritis
BACKGROUND.To date, the study of the factors involved in the glomerular-tubular pathological connections leading to damage to the tubulointerstitial tissue is one of the topical areas of nephrology. THE AIM: to study the effect of MCP-1 in the development of tubulointerstitial fibrosis as a factor in the irreversible progression of chronic renal failure. PATIENTS ANDMETHODS.Prospective observation and retrospective analysis of case histories were carried out, which included a total of 75 patients with primary chronic glomerulonephritis. RESULTS.The average age of the patients was 36.7 ± 12.3 years, of which 52 were males, 23 were women. The average length of service in a nephrological disease was 3.0 [1.0; 5.0] years. The calculated GFR values are 87.3 ± 31.2 ml / min / 1.73 m2. In the general population, the moderate degree of MCP-1 expression, estimated at 2 points, was 35 %, pronounced expression was found in 25 % of the respondents. In the mesangium of the glomeruli and in macrophages, the expressed degree of MCP-1 expression was 20 % and 16 %, respectively, which characterizes MCP-1 as a marker produced by resident cells. When studying the relationship of MCP-1 in blood with clinical parameters, a correlation was found with the values of total protein (Rs= –0.43; p CONCLUSION.The relationship of serum and tissue forms of MCP-1 with the progression of tubulointerstitial fibrosis in chronic glomerulonephritis has been demonstrated. MCP-1-induced mesangial cell plays a critical role in the development of renal tubular damage, and its increased expression is associated with progressive tubulointerstitial fibrosis and decreased renal function.
- Open Access
- 7 July 2021
- Published by Rostov State Medical University in South Russian Journal of Therapeutic Practice
- Vol. 2 (2) , 104-110
Findings from the EMPEROR-Reduced study are a tool to improve care for patients with chronic heart failure with reduced ejection fraction.Resolution of the Regional Scientific Meeting of Experts of the Southern Federal District
At online scientific expert meeting of the South region held on October 3, 2020, the results of the international multicenter study EMPEROR-Reduced were discussed. Number of proposals and recommendations were adopted for the further study of the cardiovascular and renal effects of empagliflozin, its use in clinical practice in patients with chronic heart failure.
- 7 July 2021
- Published by Rostov State Medical University in South Russian Journal of Therapeutic Practice
- Vol. 2 (2) , 104-110
Open AccessFindings from the EMPEROR-Reduced study are a tool to improve care for patients with chronic heart failure with reduced ejection fraction.Resolution of the Regional Scientific Meeting of Experts of the Southern Federal District
At online scientific expert meeting of the South region held on October 3, 2020, the results of the international multicenter study EMPEROR-Reduced were discussed. Number of proposals and recommendations were adopted for the further study of the cardiovascular and renal effects of empagliflozin, its use in clinical practice in patients with chronic heart failure.
- Open Access
- 23 November 2015
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 14 (1) , 90-96
RENAL ARTERIES REMODELLING — THE INITIATOR AND TARGET OF CARDIORENAL CONTINUUM
РЕМОДЕЛИРОВАНИЕ ПОЧЕЧНЫХ АРТЕРИЙ — ИНИЦИАТОР И МИШЕНЬ КАРДИОРЕНАЛЬНОГО КОНТИНУУМА
- 23 November 2015
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 14 (1) , 90-96
Open AccessRENAL ARTERIES REMODELLING — THE INITIATOR AND TARGET OF CARDIORENAL CONTINUUM
РЕМОДЕЛИРОВАНИЕ ПОЧЕЧНЫХ АРТЕРИЙ — ИНИЦИАТОР И МИШЕНЬ КАРДИОРЕНАЛЬНОГО КОНТИНУУМА
- Open Access
- 20 August 2011
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 10 (4) , 59-62
Renal risk factors, coronary plaque parameters, and their effects on cardiovascular prognosis in patients with coronary heart disease
Aim. To assess the impact of renal risk factors (RFs) and local vascular factors on cardiovascular survival in patients with disturbed intracoronary hemodynamics after myocardial revascularization. Material and methods. In total, 99 patients with indications for myocardial revascularization (mean age 56,5±0,8 years) were examined. All participants were divided into two groups: Group I — with 3 or less RFs, and Group II — with 4 or more RFs. The renal RFs included microalbuminuria (MAU) and glomerular filtration rate (GFR). The area of atherosclerotic plaque (SAP) and the rate of its intra-luminal growth (VAP) were calculated. Results. Group II demonstrated higher MAU levels than Group I: 171,2±23,9 vs. 112,9±11,99, respectively (р=0,03). In addition, SAP values were higher in Group II (8,02±0,22 vs. 6,94±0,29 in Group I; р=0,004), as well as VAP values (6,62±1,26 vs. 1,44±0,18 in Group I; рConclusion. Increased number of traditional RFs could be associated with increased MAU, hemodynamically significant coronary stenosis, and higher rate of atherosclerotic plaque growth.
- 20 August 2011
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 10 (4) , 59-62
Open AccessRenal risk factors, coronary plaque parameters, and their effects on cardiovascular prognosis in patients with coronary heart disease
Aim. To assess the impact of renal risk factors (RFs) and local vascular factors on cardiovascular survival in patients with disturbed intracoronary hemodynamics after myocardial revascularization. Material and methods. In total, 99 patients with indications for myocardial revascularization (mean age 56,5±0,8 years) were examined. All participants were divided into two groups: Group I — with 3 or less RFs, and Group II — with 4 or more RFs. The renal RFs included microalbuminuria (MAU) and glomerular filtration rate (GFR). The area of atherosclerotic plaque (SAP) and the rate of its intra-luminal growth (VAP) were calculated. Results. Group II demonstrated higher MAU levels than Group I: 171,2±23,9 vs. 112,9±11,99, respectively (р=0,03). In addition, SAP values were higher in Group II (8,02±0,22 vs. 6,94±0,29 in Group I; р=0,004), as well as VAP values (6,62±1,26 vs. 1,44±0,18 in Group I; рConclusion. Increased number of traditional RFs could be associated with increased MAU, hemodynamically significant coronary stenosis, and higher rate of atherosclerotic plaque growth.